Furthermore, The involvement of PAF in the development of ARF is additionally corroborated by the impact of the specific antagonist of PAF “BN-52021.” Intriguingly, the study reported that PAF blocker markedly blunt the fall in GFR confirmed by attenuation of the tissue necrosis induced by GEN (López-Novoa 1999). Here, PCLAF is linked to acute kidney injury.